ANDA 77724, held by Heritage Pharma Avet. Pramipexole Dihydrochloride.
As of Nov 16, 2026, ANDA 77724 (Pramipexole Dihydrochloride), held by Heritage Pharma Avet, was first approved by FDA on Feb 19, 2008, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 19, 2008 | Original application | Approved |
| Pramipexole Dihydrochloride0.125MG · tablet;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride0.25MG · tablet;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride0.5MG · tablet;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride1MG · tablet;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride1.5MG · tablet;oral | Pramipexole Dihydrochloride | Discontinued |
| Mar 26, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 26, 2024 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 26, 2024 | Supplement 11Labeling · Standard review | Approved | None posted |
| Mar 26, 2024 | Supplement 10Labeling · Standard review | Approved | None posted |
| Mar 23, 2012 | Supplement 6Labeling | Approved | None posted |
| Dec 24, 2009 | Supplement 2Labeling | Approved | None posted |
| Feb 19, 2008 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters